Effects of cardioactive medications on retrograde conduction: Continuing relevance for current devices

John E. O'Mara, John Devens Fisher, Sue J. Goldie, Soo G. Kim, Kevin J. Ferrick, Jay N. Gross, Eugen C. Palma

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Introduction. Retroconduction (ventriculo-atrial conduction) remains a problem for patients with implanted cardiac rhythm devices. Pacemaker algorithms can detect and terminate endless loop tachycardia (ELT), but actual prevention of ELT may require anti-arrhythmic drugs (AADs). Similarly, AADs can affect ICD rhythm discrimination algorithms that depend on atrio-ventricular ratios. There is concern whether these drugs remain effective during stress situations. Methods. Electrophysiologic studies that included retroconduction testing using slow ramp pacing were done in 1332 patients. The presence or absence of retroconduction at baseline and with drug was recorded, as was the rate at block. As a stress surrogate, isoproterenol was used to test retroconduction and reversal of drug-induced block. Results. Procainamide, mexiletine, phenytoin, disopyramide, quinidine, beta-blockers, encainide, and amiodarone caused complete retrograde block or decreased the rate at which block occurred (mean 76% of patients, p < 0.008), whereas digoxin, lidocaine, diltiazem, and verapamil did not. Isoproterenol (in the absence of AADs) increased the rate at block in 82% of 404 patients with retroconduction at baseline (p < 0.005). Of 319 patients without retroconduction at baseline, 134 (42%) developed retroconduction after isoproterenol. Isoproterenol reversed retrograde block in 39% of patients with block on an AAD. Amiodarone, digoxin, and the combination of digoxin plus a beta-blocker were most effective at resisting this reversal of ventriculo-atrial block (80%, 68%, and 75% respectively). Conclusion. Most of the AADs reviewed increase the cycle length at block or abolish retroconduction, while isoproterenol has the opposite effect. Anti-arrhythmic medications, particularly amiodarone, digoxin, and the combination of digoxin plus a beta-blocker may be considered for a patient with multiple ELT episodes or certain ICD detection problems.

Original languageEnglish (US)
Pages (from-to)49-55
Number of pages7
JournalJournal of Interventional Cardiac Electrophysiology
Volume15
Issue number1
DOIs
StatePublished - Jan 2006

Fingerprint

Anti-Arrhythmia Agents
Digoxin
Equipment and Supplies
Isoproterenol
Pharmaceutical Preparations
Amiodarone
Tachycardia
Encainide
Mexiletine
Disopyramide
Procainamide
Architectural Accessibility
Quinidine
Diltiazem
Phenytoin
Verapamil
Lidocaine

Keywords

  • Anti-arrhythmic drugs
  • Endless loop tachycardia
  • ICD detection algorithm
  • Pacemaker
  • Pacemaker-mediated tachycardia
  • Retrograde conduction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Effects of cardioactive medications on retrograde conduction : Continuing relevance for current devices. / O'Mara, John E.; Fisher, John Devens; Goldie, Sue J.; Kim, Soo G.; Ferrick, Kevin J.; Gross, Jay N.; Palma, Eugen C.

In: Journal of Interventional Cardiac Electrophysiology, Vol. 15, No. 1, 01.2006, p. 49-55.

Research output: Contribution to journalArticle

@article{d7149c33ea494df0abe0980ba8066e2b,
title = "Effects of cardioactive medications on retrograde conduction: Continuing relevance for current devices",
abstract = "Introduction. Retroconduction (ventriculo-atrial conduction) remains a problem for patients with implanted cardiac rhythm devices. Pacemaker algorithms can detect and terminate endless loop tachycardia (ELT), but actual prevention of ELT may require anti-arrhythmic drugs (AADs). Similarly, AADs can affect ICD rhythm discrimination algorithms that depend on atrio-ventricular ratios. There is concern whether these drugs remain effective during stress situations. Methods. Electrophysiologic studies that included retroconduction testing using slow ramp pacing were done in 1332 patients. The presence or absence of retroconduction at baseline and with drug was recorded, as was the rate at block. As a stress surrogate, isoproterenol was used to test retroconduction and reversal of drug-induced block. Results. Procainamide, mexiletine, phenytoin, disopyramide, quinidine, beta-blockers, encainide, and amiodarone caused complete retrograde block or decreased the rate at which block occurred (mean 76{\%} of patients, p < 0.008), whereas digoxin, lidocaine, diltiazem, and verapamil did not. Isoproterenol (in the absence of AADs) increased the rate at block in 82{\%} of 404 patients with retroconduction at baseline (p < 0.005). Of 319 patients without retroconduction at baseline, 134 (42{\%}) developed retroconduction after isoproterenol. Isoproterenol reversed retrograde block in 39{\%} of patients with block on an AAD. Amiodarone, digoxin, and the combination of digoxin plus a beta-blocker were most effective at resisting this reversal of ventriculo-atrial block (80{\%}, 68{\%}, and 75{\%} respectively). Conclusion. Most of the AADs reviewed increase the cycle length at block or abolish retroconduction, while isoproterenol has the opposite effect. Anti-arrhythmic medications, particularly amiodarone, digoxin, and the combination of digoxin plus a beta-blocker may be considered for a patient with multiple ELT episodes or certain ICD detection problems.",
keywords = "Anti-arrhythmic drugs, Endless loop tachycardia, ICD detection algorithm, Pacemaker, Pacemaker-mediated tachycardia, Retrograde conduction",
author = "O'Mara, {John E.} and Fisher, {John Devens} and Goldie, {Sue J.} and Kim, {Soo G.} and Ferrick, {Kevin J.} and Gross, {Jay N.} and Palma, {Eugen C.}",
year = "2006",
month = "1",
doi = "10.1007/s10840-006-7621-z",
language = "English (US)",
volume = "15",
pages = "49--55",
journal = "Journal of Interventional Cardiac Electrophysiology",
issn = "1383-875X",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - Effects of cardioactive medications on retrograde conduction

T2 - Continuing relevance for current devices

AU - O'Mara, John E.

AU - Fisher, John Devens

AU - Goldie, Sue J.

AU - Kim, Soo G.

AU - Ferrick, Kevin J.

AU - Gross, Jay N.

AU - Palma, Eugen C.

PY - 2006/1

Y1 - 2006/1

N2 - Introduction. Retroconduction (ventriculo-atrial conduction) remains a problem for patients with implanted cardiac rhythm devices. Pacemaker algorithms can detect and terminate endless loop tachycardia (ELT), but actual prevention of ELT may require anti-arrhythmic drugs (AADs). Similarly, AADs can affect ICD rhythm discrimination algorithms that depend on atrio-ventricular ratios. There is concern whether these drugs remain effective during stress situations. Methods. Electrophysiologic studies that included retroconduction testing using slow ramp pacing were done in 1332 patients. The presence or absence of retroconduction at baseline and with drug was recorded, as was the rate at block. As a stress surrogate, isoproterenol was used to test retroconduction and reversal of drug-induced block. Results. Procainamide, mexiletine, phenytoin, disopyramide, quinidine, beta-blockers, encainide, and amiodarone caused complete retrograde block or decreased the rate at which block occurred (mean 76% of patients, p < 0.008), whereas digoxin, lidocaine, diltiazem, and verapamil did not. Isoproterenol (in the absence of AADs) increased the rate at block in 82% of 404 patients with retroconduction at baseline (p < 0.005). Of 319 patients without retroconduction at baseline, 134 (42%) developed retroconduction after isoproterenol. Isoproterenol reversed retrograde block in 39% of patients with block on an AAD. Amiodarone, digoxin, and the combination of digoxin plus a beta-blocker were most effective at resisting this reversal of ventriculo-atrial block (80%, 68%, and 75% respectively). Conclusion. Most of the AADs reviewed increase the cycle length at block or abolish retroconduction, while isoproterenol has the opposite effect. Anti-arrhythmic medications, particularly amiodarone, digoxin, and the combination of digoxin plus a beta-blocker may be considered for a patient with multiple ELT episodes or certain ICD detection problems.

AB - Introduction. Retroconduction (ventriculo-atrial conduction) remains a problem for patients with implanted cardiac rhythm devices. Pacemaker algorithms can detect and terminate endless loop tachycardia (ELT), but actual prevention of ELT may require anti-arrhythmic drugs (AADs). Similarly, AADs can affect ICD rhythm discrimination algorithms that depend on atrio-ventricular ratios. There is concern whether these drugs remain effective during stress situations. Methods. Electrophysiologic studies that included retroconduction testing using slow ramp pacing were done in 1332 patients. The presence or absence of retroconduction at baseline and with drug was recorded, as was the rate at block. As a stress surrogate, isoproterenol was used to test retroconduction and reversal of drug-induced block. Results. Procainamide, mexiletine, phenytoin, disopyramide, quinidine, beta-blockers, encainide, and amiodarone caused complete retrograde block or decreased the rate at which block occurred (mean 76% of patients, p < 0.008), whereas digoxin, lidocaine, diltiazem, and verapamil did not. Isoproterenol (in the absence of AADs) increased the rate at block in 82% of 404 patients with retroconduction at baseline (p < 0.005). Of 319 patients without retroconduction at baseline, 134 (42%) developed retroconduction after isoproterenol. Isoproterenol reversed retrograde block in 39% of patients with block on an AAD. Amiodarone, digoxin, and the combination of digoxin plus a beta-blocker were most effective at resisting this reversal of ventriculo-atrial block (80%, 68%, and 75% respectively). Conclusion. Most of the AADs reviewed increase the cycle length at block or abolish retroconduction, while isoproterenol has the opposite effect. Anti-arrhythmic medications, particularly amiodarone, digoxin, and the combination of digoxin plus a beta-blocker may be considered for a patient with multiple ELT episodes or certain ICD detection problems.

KW - Anti-arrhythmic drugs

KW - Endless loop tachycardia

KW - ICD detection algorithm

KW - Pacemaker

KW - Pacemaker-mediated tachycardia

KW - Retrograde conduction

UR - http://www.scopus.com/inward/record.url?scp=33745650704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745650704&partnerID=8YFLogxK

U2 - 10.1007/s10840-006-7621-z

DO - 10.1007/s10840-006-7621-z

M3 - Article

C2 - 16680550

AN - SCOPUS:33745650704

VL - 15

SP - 49

EP - 55

JO - Journal of Interventional Cardiac Electrophysiology

JF - Journal of Interventional Cardiac Electrophysiology

SN - 1383-875X

IS - 1

ER -